Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Aspirin helps increase survival from TB meningitis by reducing brain inflammation and preventing the disease from blocking blood vessels in the brain that cause parts of the brain to die, commonly called ‘stroke’.

Old drub new life june18

These findings were recently published in eLife, from a phase II clinical trial led by Professor Guy Thwaites

With funding from the Wellcome Trust, OUCRU researchers  investigated whether the addition of aspirin at low (81mg/day) or high (1000mg/day) dose, or placebo, to the first 60 days of current standard TB meningitis treatment (anti-TB drugs and steroids) was safe and reduced new strokes or death from this severe disease.

Professor Thwaites was recently interviewed about this work for the eLife podcast, and you can listen to the interview on eLife podcast (at 14:45 on the clock)

eLife have also published an insight article, which discusses this study and its results